Taking stock of technology

Jun 19, 2013 by Jennifer Doody

At the recent Harvard IT Summit, Anne Margulies, vice president and University chief information officer, mentioned how Harvard had been at the forefront of information technology since its inception, even to the point of naming the burgeoning field. Quoting from a then-futuristic piece titled "Management in the 1980s" in a 1958 issue of the Harvard Business Review, Margulies noted that the article declared, "We shall call it 'information technology.'"

"Our field didn't even have a name until Harvard gave it one just 55 years ago," Margulies told a crowd of about 1,000 in Sanders Theatre on June 6. "Since then, it has been ever-changing, incredibly rapidly, and increasingly important to everything we do … And as a result, we have some of the most exciting, challenging, and rewarding jobs on the planet."

The summit's keynote speaker was Jonathan Zittrain, professor at Harvard Law School, Harvard Kennedy School, and the School of Engineering and Applied Sciences, as well as the co-founder of the Berkman Center for Internet and Society at Harvard University. He devoted his lecture to the potential "end of .edu."

Zittrain recalled the words of Jonas Salk, who developed the vaccine for while a researcher at the University of Pittsburgh. Asked about a possible patent for his discovery, Salk declared that the people owned it, much like they owned the sun. Salk said "there (was) no patent" for the vaccine.

For Salk, Zittrain said, the greatest honor was to make advances in his field and to see them have an impact to improve the world. Zittrain added that had Salk patented the vaccine, it would have been worth approximately $7 billion to the University of Pittsburgh in today's dollars.

By contrast, Zittrain cited the example of , a medication developed by a pharmaceutical company to . Since patenting the drug 12 years ago, he said, has earned $125 billion from Lipitor sales.

"This raises an interesting question: What is the for great thoughts and innovation that have an impact on the world?" Zittrain asked. "What makes some thoughts more worthy for .edu to do, and others for .com to do, or is it just a matter of who gets there first?"

In fact, Zittrain said, the worlds of .edu and .com have been blending for decades. The co-transformation of eukaryotic cells, which allow researchers to inject foreign DNA into a cell and manipulate cells to accept it, was discovered by Columbia University researchers. The idea to patent the discovery, Zittrain said, "came from one of the co-inventors, Richard Axel, and it struck his other co-inventor as a rather odd thing to do."

But by working with offices at the university that fall within the .com model—offices that work closely with patenting, marketing, and promotion—university research can result in enormous profits for an academic institution. The case discovery of eukaryotic cels, Zittrain said, resulted in $790 million in licensing fees to Columbia University.

Zittrain said that the core purposes of educational institutions such as Harvard should be grounded in four ideas: the cultivation of scholarly skills; providing access to the world's information; freely disseminating "what we know and transform from what we then learn"; and contributing "actively and fiercely" to the development of free information on "open, unowned information platforms" such as the Internet.

"But I think there is some value in separating threads that become a little too intertwined with values," Zittrain said.

"If you think it's all just cash and carry, that's not what I think we stand for here. Money is a variable, but we're probably not solving for it: We're solving for the 'Veritas' of it … to decide how much of Jonas Salk's tradition we want to do, and how much we want to go with another."

Explore further: US company sells out of Ebola toys

add to favorites email to friend print save as pdf

Related Stories

Polio vaccine developer Koprowski dies

Apr 14, 2013

Dr. Hilary Koprowski, the Polish-born researcher who developed the first successful oral vaccination for polio, died this week at his Philadelphia home. He was 96.

Harvard, MIT announce online learning partnership

May 02, 2012

(AP) -- Harvard and the Massachusetts Institute of Technology have joined forces to offer free online courses in a project aimed at attracting millions of online learners around the world, the universities announced Wednesday.

Recommended for you

US company sells out of Ebola toys

Oct 17, 2014

They might look tasteless, but satisfied customers dub them cute and adorable. Ebola-themed toys have proved such a hit that one US-based company has sold out.

Social trust eroded in Chinese product-tampering incident

Oct 14, 2014

For about a decade, Chinese consumers weren't getting what they paid for when they purchased Wuchang, a special brand of gourmet rice that has a peculiar scent. The quality was being diluted when less expensive rice was aromatized, ...

The 2014 Nobel Prizes at a glance

Oct 13, 2014

(AP)—All winners of the 2014 Nobel Prizes have now been announced, starting with the medicine award a week ago and ending with the economics prize on Monday.

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

rsklyar
1 / 5 (3) Jun 20, 2013
Some else stories which never be published in this Harvard University's official newspaper. They are about stealing of both the ideas and money of taxpayers by numerous swindlers from Department of Chemistry and Chemical Biology and School of Engineering and Applied Science at http://issuu.com/...vard_mit and http://issuu.com/...llsens12
Their plagiaristic "masterpieces" titled Macroporous nanowire nanoelectronic scaffolds for synthetic tissues (DOI: 10.1038/NMAT3404) and Outside Looking In: Nanotube Transistor Intracellular Sensors (dx.doi.org/10.1021/nl301623p) were funded by NIH Director's Pioneer Award (1DP1OD003900) and a McKnight Foundation Technological Innovations in Neurosciences Award, also a Biotechnology Research Endowment from the Department of Anesthesiology at Children's Hospital Boston and NIH grant GM073626, and NIH grants DE013023 and DE016516.